Hasil Pencarian - Aref Al-Kali

Perbaiki Hasil
  1. 1
    Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia

    Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia oleh Aref Al-kali M.D., Alok Oswal, Arafat Tfayli

    Diterbitkan 2008-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The Role of Monoclonal Antibodies in the Management of Leukemia

    The Role of Monoclonal Antibodies in the Management of Leukemia oleh Mohamad Cherry, Aref Al-Kali, Ali Al-Ameri, Alessandra Ferrajoli

    Diterbitkan 2010-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhibitor

    Determinants of survival and retrospective comparisons of 183 clinical trial patients with myelofibrosis treated with momelotinib, ruxolitinib, fedratinib or BMS- 911543 JAK2 inhib... oleh Naseema Gangat, Kebede H. Begna, Aref Al-Kali, William Hogan, Mark Litzow, Animesh Pardanani, Ayalew Tefferi

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy

    Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy oleh Lauren A. Dalvin, Timothy W. Olsen, Sophie J. Bakri, Kristen McCullough, Ayalew Tefferi, Aref Al-Kali

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

    A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome oleh Jehad Almasri, Hassan B. Alkhateeb, Belal Firwana, Mohamad Bassam Sonbol, Moussab Damlaj, Zhen Wang, M. Hassan Murad, Aref Al-Kali

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Erythrocytosis associated with <i>EPAS1</i>(<i>HIF2A</i>), <i>EGLN1</i>(<i>PHD2</i>), <i>VHL, EPOR</i> or <i>BPGM</i> mutations: The Mayo Clinic experience

    Erythrocytosis associated with <i>EPAS1</i>(<i>HIF2A</i>), <i>EGLN1</i>(<i>PHD2</i>), <i>VHL, EPOR</i> or <i>BPGM</i> mutations: The Mayo Clinic experience oleh Naseema Gangat, Jennifer L. Oliveira, Tavanna R Porter, James D. Hoyer, Aref Al-Kali, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

    Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients oleh Aref Al-Kali, Sergej Konoplev, Erpei Lin, Tapan Kadia, Stefan Faderl, Farhad Ravandi, Mohamad Ayoubi, Mark Brandt, Jorge E. Cortes, Hagop Kantarjian, Gautam Borthakur

    Diterbitkan 2012-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant

    Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant oleh Ayalew Tefferi, Animesh Pardanani, Kebede H. Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    One thousand patients with essential thrombocythemia: the Mayo Clinic experience

    One thousand patients with essential thrombocythemia: the Mayo Clinic experience oleh Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H. Begna, Michelle A. Elliott, Alexandra P. Wolanskyj-Spinner, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS

    S263: CYTOPENIAS, AGE AND CAR-HEMATOTOX SCORE PREDICT THE DEVELOPMENT OF POST CAR T-CELL THERAPY-RELATED MYELOID NEOPLASMS oleh Mark Gurney, Hassan Alkhateeb, Syed Shah, Radhika Bansal, Matthew Hathcock, Allison Rosenthal, Mohamed Kharfan-Dabaja, Taxiarchis Kourelis, Mrinal Patnaik, Dong Chen, Aref Al-Kali, Saad Kenderian, Yi Lin, Mithun Shah

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia

    Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia oleh Naseema Gangat, Isla Johnson, Kristen McCullough, Faiqa Farrukh, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Mark Litzow, William Hogan, Mithun Shah, Mrinal Patnaik, Animesh Pardanani, Ayalew Tefferi

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs

    Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs oleh Ahmad Ghorab, Aref Al-Kali, Michelle Elliot, Naseema Gangat, Hasan Alkhateeb, Mithun Shah, Yuanhang Liu, Cecilia Arana Yi, Hemant Murthy, Mohamed Kharfan-Dabaja, Ayalew Tefferi, Mrinal Patnaik, Mark Litzow, Talha Badar

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab

    Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab oleh Krasimira A. Rozenova, Anja C. Roden, Christopher Hartley, Jess F. Peterson, Gregory E. Otteson, Aref Al-Kali, Harry E. Fuentes Bayne, Mithun V. Shah, Mrinal S. Patnaik, Rebecca L. King, Daniel P. Larson

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)

    Isolated anemia in patients with large granular lymphocytic leukemia (LGLL) oleh Youssef Salama, Fang Zhao, Jennifer L. Oliveira, Ji Yuan, Dragan Jevremovic, Ronald S. Go, Wei Ding, Sameer A. Parikh, Mithun V. Shah, Paul J. Hampel, Aref Al-Kali, William G. Morice, Min Shi

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy

    Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy oleh Zhuoer Xie, Terra Lasho, Arushi Khurana, Alejandro Ferrer, Christy Finke, Abhishek A. Mangaonkar, Stephen Ansell, Jenna Fernandez, Mithun Vinod Shah, Aref Al-Kali, Naseema Gangat, Jithma Abeykoon, Thomas E. Witzig, Mrinal M. Patnaik

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy

    Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy oleh Naseema Gangat, Rimal Ilyas, Isla M Johnson, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Ayalew Tefferi

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation

    DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation oleh Majd Jawad, Michelle Afkhami, Michelle Afkhami, Yi Ding, Xiaohui Zhang, Peng Li, Kim Young, Mina Luqing Xu, Wei Cui, Yiqing Zhao, Stephanie Halene, Aref Al-Kali, David Viswanatha, Dong Chen, Rong He, Gang Zheng, Gang Zheng

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

    Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study oleh Zhuoer Xie, Ahmad Nanaa, Antoine N. Saliba, Rong He, David Viswanatha, Phuong Nguyen, Dragan Jevremovic, Patricia Greipp, Mohamad E. Salama, Naseema Gangat, Hassan B. Alkhateeb, Ayalew Tefferi, Mark Litzow, Mrinal Patnaik, Mithun Shah, Aref Al-Kali

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

    P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE oleh Rami Basmaci, Anmol Baranwal, Rong He, David Viswanatha, Patricia Greipp, James M Foran, Cecilia Arana Yi, Mithun Shah, Abhishek Mangaonkar, Mark Litzow, William Hogan, Kebede Benga, Antoine Saliba, Naseema Gangat, Ayalew Tefferi, Mrinal Patnaik, Aref Al-Kali, Hassan Alkhateeb

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience

    Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience oleh Ayalew Tefferi, Naseema Gangat, Mithun Shah, Hassan Alkhateeb, Mrinal S. Patnaik, Aref Al-Kali, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Christopher C. Hook, Abhishek Mangaonkar, David Viswanatha, Dong Chen, Animesh Pardanani, Rhett P. Ketterling, Kebede H. Begna

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: